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.  Recruitment and Follow-Up by Cohort  
Catchment Area  	Sampling Frame 	Recruitment 	PR (%) 	N° of Participants 		Follow-Up 
		Timeline 
(Years) 	Invitation 		In Database 	Analyzed 		Last 
(Year) 	Median in Years 
(5–95% Interval) 
Ohasama, Iwate, Japan 	People aged ≥40 years 	1988–1994 	Address list 	78 	1535 	1317 		2015 	22.0 (5.0–26.8) 
JingNing, Zhejiang, China 	Family-based random sample 	2003–2008 	All villagers invited 	62 	895 	850 		2012 	4.0 (3.5–7.6) 
Oktyabrsky, Novosibirsk, Russian Federation 	Family-based random sample 	1999–2001 	Address list 	68 	306 	300 		2016 	16.4 (8.1–17.5) 
Niepolomice, Kraków, Poland 	Family-based random sample 	1999–2008 	Address list 	54 	413 	389 		2014 	13.5 (6.1–14.3) 
Gdańsk, Poland 	Family-based random sample 	2008–2010 	Address list 	90 	215 	212 		2014 	5.6 (4.7–6.7) 
Pilsen, Czech Republic 	Family-based random sample 	2000–2001 	Address list 	82 	174 	165 		2015 	14.1 (13.8–14.4) 
Padova, Italy 	Family-based random sample 	1999–2007 	Address list 	73 	314 	314 		2013 	13.3 (12.6–14.5) 
Noordkempen, Belgium 	Family-based random sample 	1985–2008 	Address list 	78 	2904 	1410 		2016 	22.8 (8.1–26.2) 
Uppsala, Sweden 	Men aged 69–74 years 	1991–1995 	Population census 	73 	1143 	1096 		2015 	15.2 (3.5–22.2) 
Copenhagen County, Denmark 	Stratified random sample of women and men aged 30, 40, 50 and 60 years 	1993–1997 	Population registry 	83 	2311 	2142 		2010 	16.3 (5.1–17.3) 
Dublin, Ireland 	Bank employees working at branches across Ireland 	1989–1991 	All invited 	14 	981 	930 		2007 	17.6 (16.4–18.2) 
Maracaibo, Venezuela 	City residents aged ≥55 years 	1998–2010 	Population census 	71 	604 	589 		2012 	8.1 (1.7–13.7) 
Montevideo, Uruguay 	Age-stratified random sample 	1995–1998 	Members of a health insurance organization 	78 	1859 	1438 		2007 	9.0 (4.4–10.8) 





.  Office Blood Pressure Measurement by Cohort  
Study Cohorts 	N° of 
Subjects 	Monitoring Device 	Position 	Minutes of Rest 	Observers 
					
Ohasama, Iwate, Japan 	1317 	Elquest USM-700F2 	Sitting 	2 	Nurses 
JingNing, Zhejiang, China 	850 	Mercury sphygmomanometer 	Sitting 	5 	Physicians 
Oktyabrsky, Novosibirsk, Russia 	300 	Mercury sphygmomanometer 	Sitting 	5 	Technicians 
Niepolomice, Kraków, Poland 	389 	Mercury sphygmomanometer 	Sitting 	10 	Technicians 
Gdańsk, Poland 	212 	Mercury sphygmomanometer 	Sitting 	10 	Technicians 
Pilsen, Czech Republic 	165 	Mercury sphygmomanometer 	Sitting 	10 	Technicians 
Padova, Italy 	314 	Mercury sphygmomanometer 	Sitting 	10 	Technicians 
Noordkempen, Belgium 	1410 	Mercury sphygmomanometer 	Sitting 	5 	Nurses 
Uppsala, Sweden 	1096 	Mercury sphygmomanometer 	Supine 	10 	Technicians 
Copenhagen County, Denmark 	2142 	Mercury sphygmomanometer 	Sitting 	5 	Technicians 
Dublin, Ireland 	930 	Mercury sphygmomanometer 	Sitting 	5 	Nurses 
Maracaibo, Venezuela 	589 	Dinamap 8100 	Sitting 	5 	Physicians 






.  Ambulatory Blood Pressure Monitoring by Cohort  
Study Cohorts 	N° of 
Subjects 	Monitoring Device 	Programmed Reading Intervals minutes 		N° of 24-h Readings 
			Day 	Night 		Programmed 	Median 	P5 	P25 	P75 	P95 
Ohasama, Iwate, Japan 	1317 	ABPM-630, Nippon Colin 	30 	30 		48 	45 	36 	42 	48 	50 
JingNing, Zhejiang, China 	850 	90207, SpaceLabs 	20 	45 		65 	56 	48 	55 	57 	62 
Oktyabrsky, Novosibirsk, Russia 	300 	90202, SpaceLabs 	15 	30 		76 	71 	56 	65 	75 	78 
Niepolomice, Kraków, Poland 	389 	90202, SpaceLabs 	15 	30 		76 	74 	54 	63	77 	79 
Gdańsk, Poland 	212 	TM-2430, A&D 	20 	45 		65 	62 	50 	59 	64 	65 
Pilsen, Czech Republic 	165 	90202, SpaceLabs 	20 	45 		65 	76 	56 	71 	80 	82 
Padova, Italy 	314 	90202, SpaceLabs 	15 	30 		76 	76 	64 	74 	77 	78 
Noordkempen, Belgium 	1410 	90202, SpaceLabs 	20 	40 		55 	53 	37 	41 	56 	58 
Uppsala, Sweden 	1096 	Accutracker II 	20–30 	20–60 		41–72 	65 	44 	52 	75 	84 
Copenhagen County, Denmark 	2142 	TM-2421, A&D 	15 	30 		80 	80 	68 	78 	81	83 
Dublin, Ireland 	930 	90202 and 90207, Spacelabs 	30 	30 		48 	46 	38 	44 	48 	49 
Maracaibo, Venezuela 	589 	90207, SpaceLabs 	15 	30 		80 	67 	51 	61 	71 	77 
Montevideo, Uruguay 	1438 	90207, SpaceLabs 	20 	40 		60 	37 	30 	34 	40 	43 





   Numerical Data for Figure 2  
Blood Pressure Categories 	Number at Risk 	Total Mortality 	Cardiovascular Events 	Coronary Events 	Stroke 
		N° of
Events 	Incidence, % 	N° of
Events 	Incidence, % 	N° of
Events 	Incidence, % 	N° of
Events 	Incidence, % 
Office systolic, mm Hg 									
<120 	3407 	353 	6.82 	208 	4.42 	94 	2.07 	76 	1.46 
120-129 	2223 	416 	13.04 	301 	10.25 	129 	4.31 	126 	3.86 
130-139 	1882 	510 	19.05 	355 	14.64 	165 	6.85 	150 	5.44 
140-159 	2310 	861 	28.63 	623 	23.83 	266 	9.54 	246 	8.66 
≥160 	1330 	588 	40.31 	501 	40.91 	239 	17.80 	197 	14.66 
24-Hour systolic, mm Hg 							 	 	
<115 	3233 	395 	8.52 	235 	5.48 	112 	2.68 	83 	1.69 
115-124 	3321 	637 	13.30 	445 	10.26 	195 	4.35 	177 	3.69 
125-129 	1396 	378 	19.50 	269 	15.88 	118 	7.08 	97 	5.16 
130-144 	2249 	824 	29.04 	617 	25.24 	278 	10.98 	258 	9.49 
≥145 	953 	494 	47.56 	422 	49.15 	190 	19.19 	180 	19.19 
Office diastolic, mm Hg 	 								
<80 	5650 	1155 	14.56 	761 	10.65 	325 	4.57 	329 	4.18 
80-89 	3227 	866 	20.07 	610 	16.33 	282 	6.99 	238 	5.78 
90-99 	1639 	534 	26.19 	452 	25.87 	208 	11.17  	171 	8.85 
≥100 	636 	173 	26.66 	165 	28.19 	78 	12.60 	57 	9.17 
24-Hour diastolic, mm Hg 									
<75 	6656 	1442 	15.41 	966 	11.61 	436 	5.21 	379 	4.08 
75-79 	2078 	581 	21.15 	406 	16.73 	177 	7.07 	173 	6.45 
80-89 	1894 	553 	23.68 	463 	23.22 	217 	10.01 	178 	8.12 






   Systolic Ambulatory Pressure Levels Yielding Similar 10-Year Risk as Office Thresholds in Untreated Participants 
Endpoints (n)  	Office SBP, mm Hg 	10-Year Absolute Risk, % 	Ambulatory SBP (95% CI), mm Hg
			24-Hour 	Daytime 	Nighttime 
Total mortality (1716) 	120 	2.70 	117.6 (115.4‑119.9)	121.5 (118.2‑124.8)	106.4 (103.8‑109.1)
	130 	2.91 	123.6 (122.7‑124.5)	129.8 (128.7‑130.9)	112.5 (111.3‑113.6)
	140 	3.13 	129.6 (128.0‑131.2)	138.0 (135.6‑140.4)	118.5 (116.7‑120.4)
	160 	3.63 	141.6 (136.9‑146.3)	153.2 (149.0‑157.4)	130.7 (125.2‑136.1)
Cardiovascular mortality (592) 	120 	0.69 	119.9 (117.6‑122.1)	125.1 (122.5‑127.7)	107.7 (104.5‑110.9)
	130 	0.78 	124.8 (123.4‑126.1)	130.9 (129.5‑132.3)	113.4 (111.7‑115.1)
	140 	0.88 	129.6 (127.8‑131.4)	136.7 (134.9‑138.6)	119.1 (116.9‑121.3)
	160 	1.12 	139.4 (134.9‑143.9)	148.4 (143.4‑153.4)	130.5 (124.3‑136.7)
Cardiovascular events (1206) 	120	2.93 	118.2 (116.6‑119.9)	123.1 (121.0‑125.3)	105.8 (103.7‑107.9)
	130	3.31 	123.8 (122.9‑124.7)	129.9 (128.9‑130.9)	112.6 (111.6‑113.7)
	140	3.73 	129.4 (128.1‑130.6)	136.6 (135.2‑138.0)	119.4 (117.7‑121.2)
	160	4.76 	140.5 (137.2‑143.8)	150.0 (145.9‑154.2)	133.0 (128.4‑137.7)
Coronary (555) 	120 	1.33 	118.5 (115.3‑121.7)	123.4 (119.6-127.1)	106.7 (102.7‑110.8)
	130 	1.45 	123.2 (122.0‑124.4)	128.9 (127.5‑130.2)	112.4 (110.9‑113.8)
	140 	1.58 	127.9 (125.9‑129.9)	134.4 (132.1‑136.8)	118.0 (115.6‑120.4)
	160 	1.88 	137.3 (130.7‑143.8)	145.5 (137.8‑153.2)	129.2 (121.2‑137.3)
Stroke (456) 	120 	1.05 	116.2 (113.8‑118.7)	121.4 (118.3‑124.4)	103.0 (100.0‑106.1)
	130 	1.28 	123.2 (121.9‑124.5)	129.4 (127.9‑131.0)	111.6 (110.0‑113.1)
	140 	1.55 	130.2 (129.2‑131.2)	137.5 (136.3‑138.7)	120.2 (118.7‑121.6)





   Diastolic Ambulatory Pressure Levels Yielding Similar 10-Year Risk as Office Thresholds in Untreated Participants  
Endpoints (n)  	Office DBP, mm Hg 	10-Year Absolute Risk, % 	Ambulatory DBP (95% CI), mm Hg
			24-Hour 	Daytime 	Nighttime 
Total mortality (1716) 	80 	2.88 	75.6 (75.1‑76.0)	80.5 (79.9‑81.1)	66.6 (66.0‑67.2)
	90 	3.17 	80.8 (78.7‑82.9)	87.6 (84.5‑90.7)	71.8 (69.6‑74.0)
	100 	3.49 	85.8 (82.3‑89.3)	93.1 (90.2‑95.9)	76.9 (72.6‑81.3)
Cardiovascular mortality (592) 	80 	0.76	76.7 (75.7‑77.7)	81.6 (80.4‑82.7)	67.7 (66.5‑68.9)
	90 	0.89 	81.2 (79.2‑83.2)	87.2 (84.8‑89.6)	72.8 (70.5‑75.2)
	100 	1.05 	85.6 (82.0‑89.2)	92.3 (88.7‑95.9)	77.9 (73.6‑82.2)
Cardiovascular events (1206) 	80	3.26 	75.3 (74.8-75.8)	80.2 (79.6-80.8)	66.4 (65.7-67.0)
	90	3.88 	80.7 (79.3-82.0)	87.1 (85.2-88.9)	72.5 (71.0-74.0)
	100	4.62 	86.0 (83.3-88.7)	93.2 (90.7-95.7)	78.6 (75.6-81.7)
Coronary (555) 	80 	1.44	74.6 (73.7-75.4)	79.2 (77.9-80.4)	65.6 (64.6-66.5)
	90 	1.61 	79.8 (77.3-82.3)	86.3 (82.0-90.6)	71.8 (68.9-74.7)
	100 	1.82 	84.7 (80.1-89.4)	91.8 (87.0-96.7)	77.8 (72.3-83.2)
Stroke (456) 	80	1.27	75.9 (75.2-76.5)	80.9 (80.1-81.6)	66.8 (66.0-67.7)
	90	1.62 	81.8 (79.9-83.8)	88.2 (85.7-90.8)	73.8 (71.3-76.2)









   Systolic Ambulatory Pressure Levels Yielding Similar 10-Year Risk as Office Thresholds in Participants with Diary 
Endpoints (n)  	Office SBP, mm Hg 	10-Year Absolute Risk, % 	Ambulatory SBP (95% CI), mm Hg
			24-Hour 	Daytime 	Nighttime 
Total mortality (1489) 	120 	3.72 	119.3 (116.9‑121.7)	123.0 (120.2‑125.8)	107.6 (104.8‑110.3)
	130 	4.02 	124.4 (123.4‑125.5)	129.4 (128.3‑130.5)	112.5 (111.2‑113.9)
	140 	4.34 	129.6 (128.2‑130.9)	135.8 (134.3‑137.3)	117.5 (116.1‑118.9)
	160 	5.05 	139.8 (135.5‑144.2)	148.6 (143.4‑153.8)	127.4 (122.9‑132.0)
Cardiovascular mortality (496) 	120 	0.84 	119.8 (117.1‑122.5)	123.6 (120.5‑126.8)	108.1 (105.0‑111.1)
	130 	0.97 	124.5 (122.8‑126.2)	129.2 (127.4‑131.1)	112.9 (110.9‑114.9)
	140 	1.11 	129.2 (127.9‑130.6)	134.8 (133.5‑136.2)	117.8 (116.2‑119.5)
	160 	1.45 	138.7 (135.6‑141.7)	146.0 (142.5‑149.6)	127.6 (124.1‑131.1)
Cardiovascular events (1004) 	120	4.15 	120.1 (118.6‑121.6)	124.5 (122.8‑126.2)	108.0 (106.2‑109.7)
	130	4.71 	124.6 (123.8‑125.5)	129.7 (128.9‑130.6)	112.9 (112.0‑113.9)
	140	5.34 	129.2 (128.3‑130.1)	134.9 (134.0‑135.8)	117.9 (116.9‑118.9)
	160	6.88 	138.3 (135.9‑140.7)	145.3 (142.5‑148.1)	127.8 (125.1‑130.5)
Coronary (387) 	120 	1.75 	121.3 (119.2‑123.3)	125.8 (123.4-128.3)	109.4 (107.2‑111.7)
	130 	1.93 	125.3 (124.5‑126.1)	130.4 (129.5‑131.3)	113.7 (112.8‑114.6)
	140 	2.13 	129.3 (127.7‑130.9)	135.0 (133.3‑136.7)	118.0 (116.2‑119.7
	160 	2.60 	137.4 (132.7‑142.1)	144.1 (138.7‑149.6)	126.5 (121.4‑131.6)
Stroke (458) 	120 	1.56 	120.4 (118.1‑122.6)	124.6 (121.9‑127.3)	108.3 (105.8‑110.9)
	130 	1.81 	124.7 (123.5‑126.0)	129.6 (128.2‑131.0)	113.1 (111.7‑114.4)
	140 	2.10 	129.1 (128.1‑130.0)	134.7 (133.7‑135.6)	117.8 (116.8‑118.8)





   Diastolic Ambulatory Pressure Levels Yielding Similar 10-Year Risk as Office Thresholds in Participants with Diary  
Endpoints (n)  	Office DBP, mm Hg 	10-Year Absolute Risk, % 	Ambulatory DBP (95% CI), mm Hg
			24-Hour 	Daytime 	Nighttime 
Total mortality (1489) 	80 	4.00 	75.1 (74.4‑75.9)	79.1 (78.1‑80.0)	65.7 (64.8‑66.6)
	90 	4.43 	80.0 (78.5‑81.4)	84.8 (83.1‑86.5	70.8 (69.1‑72.5)
	100 	4.91 	84.8 (81.4‑88.2)	90.5 (86.6‑94.4)	75.9 (72.1‑79.7)
Cardiovascular mortality (496) 	80 	0.96	76.1 (74.8‑77.3)	79.8 (78.3‑81.4)	67.0 (65.6‑68.3)
	90 	1.18 	81.0 (79.9‑82.1)	85.7 (84.4‑87.1)	72.1 (70.7‑73.4)
	100 	1.44 	85.9 (83.2‑88.7)	91.6 (88.3‑94.9)	77.2 (74.2‑80.2)
Cardiovascular events (1004) 	80	4.56 	75.0 (74.4-75.7)	79.1 (78.3-79.8)	65.5 (64.7-66.2)
	90	5.68 	80.5 (79.7-81.3)	85.3 (84.3-86.2)	71.6 (70.6-72.7)
	100	7.07 	86.0 (84.0-87.9)	91.5 (89.2-93.8)	77.8 (75.4-80.1)
Coronary (387) 	80 	1.85	74.6 (73.8-75.4)	78.7 (77.7-79.7)	64.9 (64.0-65.9)
	90 	2.23 	79.8 (78.5-81.2)	84.6 (83.0-86.1)	70.8 (69.2-72.4)
	100 	2.69 	85.0 (81.9-88.1)	90.4 (86.8-94.0)	76.7 (72.9-80.4)
Stroke (458) 	80	1.81	75.8 (74.8-76.9)	79.8 (78.6-80.9)	66.6 (65.5-67.7)
	90	2.29 	80.8 (79.7-81.9)	85.6 (84.3-86.9)	72.0 (70.8-73.3)
	100	2.90 	85.8 (83.2-88.5)	91.4 (88.3-94.5)	77.5 (74.5-80.4)








